Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 3 1

Status

Unknown 139Not yet recruiting 51Recruiting 43Completed 40Active not recruiting 8Withdrawn 3Terminated 3Enrolling by invitation 1Available 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × anlotinib × Clear all
NCT06507891 2024-07-18

A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Terminated
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03866980 2024-04-03

A Study of Anti-PD-1 AK105 in Patients With Metastatic Nonsquamous Non-small Cell Lung Cancer

Akeso

Phase 3 Terminated
164 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02558348 2019-06-19

AL3818

Advenchen Laboratories, LLC

Phase 1/2 Terminated
12 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡